Market Research Report
Chronic Kidney Disease: Global Markets and Technologies Through 2023
|Published by||BCC Research||Product code||830795|
|Published||Content info||153 Pages
Delivery time: 1-2 business days
|Chronic Kidney Disease: Global Markets and Technologies Through 2023|
|Published: April 22, 2019||Content info: 153 Pages||
The global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate (CAGR) of 3.8% for the period of 2018-2023.
Pharmaceuticals as a segment of chronic kidney disease market should grow from $68.0 billion in 2018 to reach $81.3 billion by 2023 at a CAGR of 3.6% for the period of 2018-2023.
Medical devices as a segment of chronic kidney disease market should grow from $11.0 billion in 2018 to reach $13.7 billion by 2023 at a CAGR of 4.4% for the period of 2018-2023.
Five-year projections for market activity and value are provided. Treatment types and trends for acute and chronic kidney failure, pricing considerations for medications, dialysis products (dialysis machines, dialysates and dialyzers), therapies, surgical procedures, companies, industry structure and participating companies are included in the study.
Qualitative information on disease overview, epidemiology and clinical burden of CKD is covered in detail. Further, detailed description about diagnostic methods such as blood tests, medical imaging; treatment, disease management strategies like pharmacological interventions, medical device interventions such as dialysis and kidney transplantation procedures and dietary supplements are covered. Further supporting technologies such as smartphone apps, tools and emerging technologies in dialysis and kidney transplantation procedures are also covered. Special emphasis is given to new, emerging technologies for the treatment of CKD. Market specific information on global dynamics (drivers, challenges and emerging opportunities) are covered. CKD disease management involves tedious labor, safety and cost analyses, knowledge of current policies, regulations and reimbursement. Further clinical trial and patent landscape is also covered in the report. Profiles and the overall competitive landscape of companies/manufacturers engaged in offering drugs and medical equipment for treating CKD is covered in the report.
Quantitative market size and forecast information is covered broadly by treatment, user settings and region. By treatment, the market is categorized into drugs (treatment of complications associated due to CKD, drugs for dialyzed patient groups, post-kidney transplantation procedures are covered) and medical equipment (dialysis-hemodialysis, peritoneal dialysis, kidney transplantation procedure surgical equipment). By user settings the CKD market is categorized into hospitals, specialty clinics and homecare. By region the market is categorized into North America, Europe, Asia-Pacific and RoW (Latin America, Middle East and Africa).